New Stock Announcement | Guangdong Marubi Biotechnology (603983.SH) has submitted an application to the Hong Kong Stock Exchange.

According to the disclosure of the Hong Kong Stock Exchange on December 11, Guangdong Marubi Biotechnology Co., Ltd. (603983.SH) has submitted its listing application to the Main Board of the Hong Kong Stock Exchange, with Goldman Sachs and CITIC SEC as its joint sponsors. The prospectus shows that Guangdong Marubi Biotechnology is a leading Chinese beauty and cosmetics company focusing on providing anti-aging solutions to consumers. The company, driven by synthetic biology technology, has been deeply involved in the anti-aging skincare industry for over twenty years, continuously making breakthroughs in core technologies such as recombinant collagen protein through research and development. By applying cutting-edge technological innovations to skincare products with anti-wrinkle, firming, and repairing effects. According to a Frost & Sullivan report, Guangdong Marubi Biotechnology is the third largest beauty and cosmetics company in China's recombinant collagen skincare niche market based on projected retail sales in 2024.